ES2046202T3 - Un procedimiento para preparar un analogo de distamicina a. - Google Patents

Un procedimiento para preparar un analogo de distamicina a.

Info

Publication number
ES2046202T3
ES2046202T3 ES198787304442T ES87304442T ES2046202T3 ES 2046202 T3 ES2046202 T3 ES 2046202T3 ES 198787304442 T ES198787304442 T ES 198787304442T ES 87304442 T ES87304442 T ES 87304442T ES 2046202 T3 ES2046202 T3 ES 2046202T3
Authority
ES
Spain
Prior art keywords
chem
substituted
hydrogen
unsubstituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787304442T
Other languages
English (en)
Inventor
Ettore Lazzari
Federico Arcamone
Sergio Penco
Maria Antonietta Verini
Nicola Mongelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2046202T3 publication Critical patent/ES2046202T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

ANALOGOS DE DISTAMICINA A DE LA FORMULA SIGUIENTE (I) DONDE N ES 2,3 O 4; A ES UN RADICAL DIVALENTE ELEGIDO DE (II) Y -HET- DONDE HET ES UN ANILLO PENTATOMICO O HEXATOMICO HETEROMONOCICLICO, EXCEPTO PIRROL, SIENDO DICHO RADICAL NO SUSTITUIDO O SUSTITUIDO POR UNO O MAS SUSTITUYENTES ELEGIDOS DE C1-C6 ALQUILO, C1-C6 ALCOXI, CIANO Y TRIFLUOROMETILO; Y UNO DE LOS RADICALES R1 Y R2 ES HIDROGENO Y EL OTRO ES (III) A) UN GRUPO EN EL QUE R3 ES C1-C6 ALQUILO NO SUSTITUIDO O SUSTITUIDO POR ATOMOS DE HALOGENO; FENILO; O CICLOHEXILO; O B) UN GRUPO -CO-(CH2)M-R4, EN EL QUE M ES CERO,1,2 O 3 Y R4 ES HIDROGENO, HALOGENO, HIDROXI, AZIRIDINILO U OXIRANILO; O R1 Y R2 SON LO MISMO Y AMBOS HIDROGENO O AMBOS UN GRUPO C1-C6 ALQUILO NO SUSTITUIDO O SUSTITUIDO POR HALOGENO; HIDROXI; O C1-C6 ALCOXI; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES; SON AGENTES ANTITUMORALES Y ANTIVIRIASICOS.
ES198787304442T 1986-05-20 1987-05-19 Un procedimiento para preparar un analogo de distamicina a. Expired - Lifetime ES2046202T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868612218A GB8612218D0 (en) 1986-05-20 1986-05-20 Site specific alkylating agents

Publications (1)

Publication Number Publication Date
ES2046202T3 true ES2046202T3 (es) 1994-02-01

Family

ID=10598117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787304442T Expired - Lifetime ES2046202T3 (es) 1986-05-20 1987-05-19 Un procedimiento para preparar un analogo de distamicina a.

Country Status (27)

Country Link
US (1) US5017599A (es)
EP (1) EP0246868B1 (es)
JP (1) JPH0623193B2 (es)
KR (1) KR950011408B1 (es)
AT (1) ATE80617T1 (es)
AU (1) AU597659B2 (es)
BG (1) BG60531B2 (es)
BR (1) BR1101017A (es)
CA (1) CA1314551C (es)
CS (1) CS413791A3 (es)
DE (1) DE3781716T2 (es)
DK (1) DK254587A (es)
ES (1) ES2046202T3 (es)
FI (1) FI86543C (es)
GB (1) GB8612218D0 (es)
GR (1) GR3006163T3 (es)
HK (1) HK31993A (es)
HU (1) HU201336B (es)
IE (1) IE60198B1 (es)
IL (1) IL82553A (es)
MX (1) MX9203122A (es)
NZ (1) NZ220361A (es)
PT (1) PT84896B (es)
SG (1) SG3793G (es)
SU (1) SU1528316A3 (es)
UA (1) UA5928A1 (es)
ZA (1) ZA873593B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
IT1262921B (it) * 1992-01-10 1996-07-22 Federico Arcamone Agenti antitumorali analoghi di oligopeptidi pirrol-amidinici retroversi processi di preparazione e prodotti farmaceutici che li contengono
IT1271456B (it) * 1993-03-01 1997-05-28 Menarini Farma Ind Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5821258A (en) * 1994-12-27 1998-10-13 Mitsui Chemicals, Inc. Phenylbenzimidazole derivatives
CA2180206A1 (en) * 1995-06-30 1996-12-31 Motoya Ohshika Freeze-dried preparation for pharmaceutical use
GB9514993D0 (en) * 1995-07-21 1995-09-20 Pharmacia Spa Site specific phenyl nitrogen mustards
US5808087A (en) * 1995-11-29 1998-09-15 Mitsui Chemicals, Inc. Sulfonium salts of pyrrolylbenzimidazoles
EP0880499A1 (en) * 1996-02-02 1998-12-02 PHARMACIA & UPJOHN S.p.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6506906B1 (en) 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
EP1023288A1 (en) 1996-02-26 2000-08-02 California Institute Of Technology Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
US6555692B1 (en) 1996-02-26 2003-04-29 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
AU734715B2 (en) 1996-02-26 2001-06-21 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded DNA
GB9610079D0 (en) * 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9816652D0 (en) * 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816653D0 (en) * 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
KR20010063274A (ko) * 1999-12-22 2001-07-09 성재갑 〔1-｛〔1-（1,3-벤조디옥솔-5-일메틸-1ｈ-이미다졸-5-일〕메틸｝-4-(1-나프틸)-1ｈ-피롤-3-일〕（4-메틸-1-피페라지닐）메타논의 약학적 조성물
US6559125B1 (en) 2000-01-28 2003-05-06 California Institute Of Technology Polyamide-alkylator conjugates and related products and method
DE60128551D1 (de) * 2000-03-16 2007-07-05 Genesoft Inc Geladene verbindungen mit einer nukleinsäure-bindenden einheit sowie deren verwendungen
US7078536B2 (en) * 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0029004D0 (en) 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002088119A1 (en) * 2001-04-26 2002-11-07 Genesoft Pharmaceuticals, Inc Halogen-substituted thienyl compounds
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
AU2003285958A1 (en) * 2002-10-25 2004-05-25 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
WO2004052304A2 (en) 2002-12-10 2004-06-24 Oscient Pharmaceuticals Corporation Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
GB202114032D0 (en) * 2021-09-30 2021-11-17 Univ Strathclyde Antivirals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR86210E (es) * 1963-04-04 1966-03-23
DE1795539A1 (de) * 1963-07-26 1972-01-13 Farmaceutici Italia Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
DE1470284B1 (de) * 1963-07-26 1971-12-16 Farmaceutici Italia Beta-{1-Methyl-4-[1-methyl-4-(1-methyl-4-formylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido]-pyrrol-2-carboxamido}-propionamidin sowie dessen Saeureadditionssalze
FR90359E (es) * 1963-07-26 1968-02-14
NL130086C (es) * 1964-07-14 1970-06-15
GB8517922D0 (en) * 1985-07-16 1985-08-21 Erba Farmitalia Carboxamido derivatives
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法

Also Published As

Publication number Publication date
IE871292L (en) 1987-11-20
CS413791A3 (en) 1992-09-16
IE60198B1 (en) 1994-06-15
FI86543C (fi) 1992-09-10
PT84896B (pt) 1990-02-08
DK254587D0 (da) 1987-05-19
FI872173A0 (fi) 1987-05-18
DK254587A (da) 1987-11-21
IL82553A0 (en) 1987-11-30
BG60531B2 (bg) 1995-07-28
BR1101017A (pt) 1999-12-07
FI872173A (fi) 1987-11-21
US5017599A (en) 1991-05-21
EP0246868A1 (en) 1987-11-25
DE3781716T2 (de) 1993-03-11
GR3006163T3 (es) 1993-06-21
JPH0623193B2 (ja) 1994-03-30
HUT44044A (en) 1988-01-28
FI86543B (fi) 1992-05-29
SU1528316A3 (ru) 1989-12-07
UA5928A1 (uk) 1994-12-29
ATE80617T1 (de) 1992-10-15
SG3793G (en) 1993-03-12
GB8612218D0 (en) 1986-06-25
NZ220361A (en) 1990-04-26
HK31993A (en) 1993-04-08
KR950011408B1 (ko) 1995-10-04
DE3781716D1 (de) 1992-10-22
AU7316387A (en) 1987-11-26
AU597659B2 (en) 1990-06-07
KR870011129A (ko) 1987-12-21
MX9203122A (es) 1992-07-01
CA1314551C (en) 1993-03-16
PT84896A (en) 1987-06-01
HU201336B (en) 1990-10-28
IL82553A (en) 1991-06-10
EP0246868B1 (en) 1992-09-16
ZA873593B (en) 1987-11-12
JPS62294653A (ja) 1987-12-22

Similar Documents

Publication Publication Date Title
ES2046202T3 (es) Un procedimiento para preparar un analogo de distamicina a.
ES2062143T3 (es) Derivados de pirrol sustituidos con grupos acriloilo y procedimiento para su preparacion.
FI943561A0 (fi) Uudet ainekoostumukset
ES2059391T3 (es) Derivados de dihidropiridina, su preparacion y su uso.
SE8603099L (sv) Distamycinderivat och forfarande for deras framstellning
NO990578D0 (no) Diesel-brennstoff inneholdende oksygenerte forbindelser
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
EP0351255A3 (en) Derivatives of û2-(4-piperidinyl)methyl¨-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy
ES2065994T3 (es) Beta-dicetonas substituidas.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
MX15697A (es) Derivados heterotetraciclicos de lactama y procesopara su preparacion
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
SE8000138L (sv) Nya 3-cyklopentan-1,2'(1'h)-naftalen-derivat, framstellning derav och lekemedel innehallande desamma